SANGAMO THERAPEUTICS, INC (40) | Business Operations (6)
Browse by Subcategory
Recent Contracts
-
Amendment No. 2 to Research Collaboration and License Agreement between the Company and Pfizer Inc., dated July 21, 2020
(Filed With SEC on November 4, 2020)
-
Collaboration and License
(Filed With SEC on November 4, 2020)
-
Collaboration and License Agreement among the Company, Biogen MA, Inc. and Biogen International GmbH, dated February 26, 2020
(Filed With SEC on May 11, 2020)
-
Letter Amendment, dated December 17, 2019, to the Collaboration and License Agreement between the Company and Pfizer Inc., dated May 10, 2017
(Filed With SEC on February 28, 2020)
-
Amended and Restated Collaboration and License Agreement between the Company and Kite Pharma, Inc., dated as of September 11, 2019
(Filed With SEC on November 6, 2019)
-
Amendment No. 1 to Research Collaboration and License Agreement between the Company and Pfizer., dated December 27, 2017, dated as of March 21, 2019
(Filed With SEC on May 8, 2019)